# Prompts to LLM:

### Instructions ###

You are assisting a team of expert clinical pharmacists, drug interaction pharmacology researchers, and persons who edit drug interaction knowledge compendia. You help synthesize evidence about possible interactions between prescription drugs and natural products (botanical or herbal) based on the most recent and relevant information. Ground your response in factual data from your pre-train set or any context provided by the user, explicitly referencing or quoting authoritative sources when possible. In your response, think carefully and be specific about the source of the information used in each answer, and avoid citing sources if the information is not a direct citation from that source. Always explain your reasoning. Make it explicit when you base your reasoning on pharmacological inference rather than a direct citation from a textual source. Focus on factuality since you must evaluate your answer in the end. Structure your response using the following nine-item template: 

Item 1: A list of each potential mechanism, showing each step in your thinking and providing evidence to support each step involved.  

Item 2: A description of the natural product mentioned in the query. Please include a list of known names to refer to the product and note how it is prepared or consumed.  

Item 3: A summary of the pharmacokinetic properties of the natural product mentioned in the query. If available, include values for the Area Under the Curve change at therapeutic concentrations linked to a pharmacodynamic effect, information on common administration routes, and the average amount of bioactive compounds in the products. 

Item 4: A brief description of the drug mentioned in the query. Include a list of known names used to refer to the drug. 

Item 5: A summary of the pharmacokinetic properties of the drug mentioned in the query. If available, include values for the Area Under the Curve change at therapeutic concentrations linked to a pharmacodynamic effect, information on common administration routes, and standardized dosage of the drug's active ingredient.

Item 6: A summarized description of the adverse event mentioned in the query. List known potential causes and if the mentioned natural product or drug is associated with the adverse event. Include all available details regarding the average onset time of the adverse event. Include all available information regarding the likelihood of overlapping effects of the adverse event. Include all available details regarding the potential additive nature of the side effects involved in the adverse event. 

Item 7: A list and description of any mention of clinical importance for the interaction, including the frequency of the mentions. 

Item 8: A list of other drugs with similar pharmacodynamic and pharmacokinetic properties to the drug in the query that could interact with the natural product mentioned. 

Item 9: A list of other natural products with similar pharmacodynamic and pharmacokinetic properties to the natural product in the query that could interact with the drug mentioned.

Finally, classify how accurate your synthesis was. Rate your confidence in your answers on a scale of 1-5, 1 being very low and 5 being very high.

### Context ###


Include relevant items from the following information in your synthesis:
The Natural Product curcumin molecularly interacts with the Enzyme or Transporter ATP-dependent translocase ABCB1 (human). The Drug tacrolimus (anhydrous) transports the Enzyme or Transporter ATP-dependent translocase ABCB1 (human). And the Drug tacrolimus (anhydrous) is causally correlated with the Adverse Event acute kidney failure. Natural Product Ontology Identifier: http://napdi.org/napdi_srs_imports:curcuma_longa Natural Product or Constituent Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_3962 Process Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002436 Enzyme or Transporter Ontology Identifier: http://purl.obolibrary.org/obo/PR_P08183 Process or Pathway Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002020 Drug Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_61049 Causal Relation Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002610 Adverse Event Ontology Identifier: http://purl.obolibrary.org/obo/MONDO_0002492

-----

The Natural Product curcumin directly negatively regulates activity of the Enzyme or Transporter cytochrome P450 3A4 (human). The Drug tacrolimus (anhydrous) is substrate of the Enzyme or Transporter cytochrome P450 3A4 (human). And the Drug tacrolimus (anhydrous) is causally correlated with the Adverse Event peripheral neuropathy. Natural Product Ontology Identifier: http://napdi.org/napdi_srs_imports:curcuma_longa Natural Product or Constituent Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_3962 Process Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002449 Enzyme or Transporter Ontology Identifier: http://purl.obolibrary.org/obo/PR_P08684 Process or Pathway Ontology Identifier: http://purl.obolibrary.org/obo/DIDEO_00000041 Drug Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_61049 Causal Relation Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002610 Adverse Event Ontology Identifier: http://purl.obolibrary.org/obo/MONDO_0005244

-----

The Natural Product 1,8-cineole interacts with the Enzyme or Transporter cytochrome P450 3A4 (human). The Drug tacrolimus (anhydrous) molecularly interacts with the Enzyme or Transporter cytochrome P450 3A4 (human). And the Drug tacrolimus (anhydrous) is causally correlated with the Adverse Event acute kidney failure. Natural Product Ontology Identifier: http://napdi.org/napdi_srs_imports:curcuma_longa Natural Product or Constituent Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_27961 Process Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002434 Enzyme or Transporter Ontology Identifier: http://purl.obolibrary.org/obo/PR_P08684 Process or Pathway Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002436 Drug Ontology Identifier: http://purl.obolibrary.org/obo/CHEBI_61049 Causal Relation Ontology Identifier: http://purl.obolibrary.org/obo/RO_0002610 Adverse Event Ontology Identifier: http://purl.obolibrary.org/obo/MONDO_0002492

### Query ###

What are the potential mechanisms that cause an interaction between Turmeric products and Tacrolimus that may cause Nephrotoxicity?

-------

# Response from LLM:

## Potential Mechanisms of Interaction Between Turmeric and Tacrolimus Leading to Nephrotoxicity

**Item 1: Potential Mechanisms**

1. **CYP3A4 Inhibition:**
    * **Step 1:** Turmeric contains curcumin, which is known to inhibit the cytochrome P450 3A4 (CYP3A4) enzyme. 
    * **Step 2:** Tacrolimus is a substrate of CYP3A4, meaning the enzyme is responsible for metabolizing it.
    * **Step 3:** Inhibition of CYP3A4 by curcumin would lead to decreased metabolism of tacrolimus, resulting in higher blood levels of the drug.
    * **Step 4:** Elevated tacrolimus levels are associated with increased risk of nephrotoxicity (kidney damage).

2. **ABCB1 Interaction:**
    * **Step 1:** Curcumin has been shown to interact with the ATP-dependent translocase ABCB1 (also known as P-glycoprotein).
    * **Step 2:** Tacrolimus is also known to interact with ABCB1.
    * **Step 3:** The interaction of curcumin with ABCB1 could potentially alter the transport and elimination of tacrolimus, leading to increased blood levels and potential nephrotoxicity.

**Item 2: Description of Turmeric**

* **Known Names:** Turmeric, Curcuma longa, Haldi
* **Preparation/Consumption:** Turmeric is a rhizome (underground stem) that is commonly used in cooking as a spice. It can be consumed fresh, dried, powdered, or as an extract.

**Item 3: Pharmacokinetic Properties of Turmeric**

* **Limited Data:**  Specific pharmacokinetic data for turmeric and curcumin are complex and vary depending on the form consumed, dosage, and individual factors.
* **Bioavailability:** Curcumin has low bioavailability due to poor absorption and rapid metabolism.
* **Administration Routes:** Oral (most common), topical
* **Active Compounds:** Curcumin is the primary bioactive compound in turmeric.

**Item 4: Description of Tacrolimus**

* **Known Names:** Tacrolimus, Prograf, FK506
* **Use:** Immunosuppressant drug used to prevent organ rejection after transplantation.

**Item 5: Pharmacokinetic Properties of Tacrolimus**

* **Absorption:**  Well absorbed orally, but bioavailability is variable.
* **Distribution:** Widely distributed throughout the body.
* **Metabolism:** Primarily metabolized by CYP3A4 in the liver.
* **Elimination:** Excreted in feces and urine.
* **Standardized Dosage:** Varies depending on the patient's weight, organ transplanted, and other factors.

**Item 6: Description of Acute Kidney Failure**

* **Causes:**  Various factors can contribute to acute kidney failure, including:
    * Reduced blood flow to the kidneys (e.g., due to dehydration, shock)
    * Direct damage to kidney cells (e.g., by toxins, medications)
    * Obstruction of urine flow (e.g., kidney stones)
* **Tacrolimus and Nephrotoxicity:** Tacrolimus is known to be nephrotoxic, meaning it can cause kidney damage. This is a significant concern, especially at higher doses.
* **Onset Time:**  Symptoms of acute kidney failure can develop rapidly (within hours or days) or more gradually.
* **Likelihood of Overlapping Effects:**  The combination of turmeric and tacrolimus could potentially increase the risk of overlapping effects on kidney function.
* **Additive Nature of Side Effects:**  The potential for additive nephrotoxicity exists if both turmeric and tacrolimus contribute to kidney damage.

**Item 7: Clinical Importance of Interaction**

* **Limited Data:** There is limited clinical data specifically addressing the interaction between turmeric and tacrolimus.
* **Case Reports:** Some case reports suggest a possible association between turmeric use and increased tacrolimus levels, but more research is needed to confirm this.

**Item 8: Other Drugs with Similar Pharmacokinetic Properties to Tacrolimus**

* Cyclosporine
* Sirolimus
* Everolimus

**Item 9: Other Natural Products with Similar Pharmacokinetic Properties to Turmeric**

* Ginger
* Garlic
* Green tea extract

**Accuracy Rating:** 3

**Reasoning:**

While the provided information suggests potential mechanisms for interaction between turmeric and tacrolimus, the evidence is limited. More research is needed to confirm the clinical significance of this interaction. The rating reflects the uncertainty surrounding the strength and frequency of the interaction.



